BAT Science - News and Conferences

Quick Navigation

Jump to content

News and Conferences

Latest News


18 June 2018 - Clinical study shows that switching to glo reduces smokers’ exposure to harmful chemicals

A study by scientists at British American Tobacco has shown then when smokers switch completely to glo, their exposure to harmful smoke chemicals is substantially reduced, in some cases to levels comparable to those seen in smokers who quit smoking completely

5th June 2018 - Science & Technology Report 2017/18 

Our industry-leading science and Next Generation Products have been showcased in our latest Science and Technology Report.

01 May 2018 - We're going to the Genetic Toxicology Association 2018 

We’re presenting some of our latest in vitro data on next-generation products and taking part in workshops discussing latest developments in biological assessment.

07 March 2018 - BAT scientists are attending SOT 2018!

Next week our scientists are visiting San Antonio for the annual Society of Toxicology (SOT) conference.

04 November 2017- E-cig vapor does not induce genetic mutations associated with cigarette smoke exposure

E-cigarette vapour does not induce DNA mutations commonly observed with tobacco smoke exposures in lab-based tests. 

25 October 2017 - Toxicant levels are around 90% less in glo™ emissions compared to cigarette smoke

Toxicant levels in vapour from glo™ were found to be around 90%* less than in cigarette smoke.  gloTM, a tobacco-heating product, heats rather than burns tobacco and operates at much lower temperatures than a lit cigarette

25 October 2017 - Studies support the reduced-risk potential of glo™

Scientists at British American Tobacco have conducted a series of tests, the results of which help establish glo™ as having the potential to be substantially reduced risk compared to traditional cigarettes

25 October 2017 - Vapour from glo™ had little or no biological impact on cells in laboratory tests

Papers 5, 6, and 7 of the glo Special Issue detail the studies of the biological in vittro effects that glo vapour has on human cells.

25 September 2017 - Studies support reduced risk potential of the Vype ePen e-cigarette

Scientists at (BAT) have created the most comprehensive database of scientific test results, to date, for an e-cigarette (Vype ePen). The results of the studies provide evidence that suggests Vype ePen has the potential to be substantially reduced risk compared to traditional cigarettes.

03 July 2017- Key genes in nitrogen utilization in tobacco identified 

The identification of these genes could eventually lead to the development of plants that require less nitrogen and to the reduction of certain toxicants in smoke

25 June 2017 - Scratch test -- wound healing disrupted by smoke but not by Vype e-cigarette vapor

A new laboratory study reveals that cigarette smoke completely prevented wound healing at concentrations over 20% in a wound healing assay, whereas e-cigarette vapour had no effect, even at 100% concentration and double the amount of nicotine relative to smoke

04 June 2017- Vapor from novel tobacco hybrid device minimally impacts human cells 

Biological testing using aerosols from several tobacco heating products found them to have little or no impact on human cells in the lab

30 May 2017 - Tobacco hybrid emits low-toxicant, e-cig-like vapour with enhanced flavour

Scientists tested vapour produced by a hybrid tobacco device, iFuse, and compared it to that produced by an e-cigarette, Vype ePen

16 May 2017 - BAT leads the way in e-cig safety testing with new screening technique

Scientists at British American Tobacco have developed a technique that can detect unpredicted substances in e-cigarette vapour.

02 May 2017 - Making e-cigarettes allergy free: a practical guide

The first practical guide to the allergy-safe use of ingredients, such as flavourings, in e-liquid has been published.

27 April 2017 - e-cigarette vapour does not promote cancer growth in lab-based tests

A new study found no evidence that vapour from a commercially available e-cigarette promotes the development of cancer in laboratory cells. In contrast, smoke from a reference cigarette was positive for cancer-promoting activity, even at very low concentrations.

18 April 2017 - Acute exposure to Vype vapor has limited impact on gene expression in human lung cells

New research shows that at equivalent or higher doses of nicotine, acute exposure to e-cigarette vapour has very limited impact on gene expression compared to cigarette smoke.

29 March 2017 - Baltimore beckons BAT scientists for key international tox conference

Top scientists from BAT headed to Maryland, USA to present new research at the Society of Toxicology (SOT) Annual Meeting.

24 March 2017 - A new tool to predict the potential public health benefit of e-cigarettes

A new study predicts that when e-cigarettes are available as alternative to cigarettes, by 2050 the 32% of smokers in the UK that otherwise would have continued smoking would have completely switched to e-cigarettes.

21 March 2017 - Spotlight on "nicotine in all its manifestations" - BAT  shares science at SRNT

Key scientists from British American Tobacco (BAT) presented their latest research at the Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting in Florence, Italy earlier this month.

11 March 2017 - Glo, a tobacco-heating product, has significantly less impact on indoor air quality than cigarettes

New research indicates that glo, a commercial tobacco heating product (THP), has less of an impact on indoor air quality than cigarette smoke.

10 March 2017 - Citric acid has the potential to produce respiratory sensitisers in e-cigarette vapour

The use of citric acid in e-liquids needs to be investigated to further understand its potential to form potentially harmful anhydrides in the vapour.

09 March 2017 - Characterising novel tobacco heating products: a 5-step approach

5-step approach to establishing whether tobacco is being combusted or heated in a tobacco-heating product (THP) is proposed.

08 March 2017 - Award-winning research collaboration featured in special issue of Applied In Vitro Toxicology

Two new Adverse Outcome Pathways (AOPs), developed jointly by British American Tobacco (BAT) and Philip Morris International (PMI), are featured in a special issue of Applied In Vitro Toxicology (AIVT) focusing on the in vitro evaluation of next-generation nicotine products.

03 March 2017 - ‘Bespoke’ study designs central to assessment of next-generation products, BAT scientists tell NAS

Dr Marianna Gaca and Dr James Murphy were both invited to present at the National Academy of Sciences in Washington DC last week, at a committee reviewing the health effects of Electronic Nicotine Delivery Systems (ENDS).

06 February 2017 - Exposure to e-cigarette vapour causes limited impact on gene and protein expression in human lung cells

New research reveals changes in the expression levels of 123 genes when reconstituted lung tissue was exposed to cigarette smoke, compared to only two genes that could be confirmed following exposure to an e-cigarette (Vype ePen) aerosol.

15 December 2016 - ‘Lung-in-the-lab’ shows e-cigarette vapour does not cause DNA damage in human cells

E-cigarette vapour does not damage DNA, even at doses 28 times that of equivalent smoke exposure.

13 December 2016 - E-cigarettes vapour does not cause DNA mutations in lab tests

Several studies have compared the impact of e-cigarette vapour with that of cigarette smoke on cells and found that vapour has little or no effect.

09 December 2016 - e-cigarettes: using vaping robots to measure the amount of vapour delivered to lung cells in the lab

New research proves that e-cigarette aerosol droplets are effectively delivered to cell surfaces in lab-based biological tests.

Recent Conferences


18/06/18 - Aerosol Technology (AT)
15/06/18 - Global Forum on Nicotine (GFN)
14/06/18 - ISoNTech

View recent and upcoming conferences 

 
max
large
medium
small
mobile